News & Events about Dexcom Inc.
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the publication of a study Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2...
Fool.com Headlines
26days ago
A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it.If you're a long-term Dexcom (NASDAQ: DXCM) shareholder, congratulations. A $1,000 bet placed on this developer of blood sugar monitoring devices a decade ago is worth nearly $30,000 today...
Westpac Banking Corp lifted its holdings in DexCom, Inc. (NASDAQ:DXCM Get Rating) by 64.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 52,231 shares of the medical device companys stock after purchasing ...
DexCom, Inc. (NASDAQ:DXCM Get Rating) EVP Sadie Stern sold 393 shares of the businesss stock in a transaction that occurred on Monday, April 10th. The shares were sold at an average price of $112.35, for a total transaction of $44,153.55. Following the transaction, the executive vice ...
DexCom, Inc. (NASDAQ:DXCM Get Rating) EVP Sadie Stern sold 393 shares of DexCom stock in a transaction on Monday, April 10th. The shares were sold at an average price of $112.35, for a total transaction of $44,153.55. Following the completion of the transaction, the executive vice president ...